Transparent Life: Application for the Patent Certificate of the Invention of Obtaining Hybridoma Cell Line 1C2B8-2 and its Secreted Antibodies.

Through life announcement, the company and its wholly-owned subsidiaries have recently received a patent certificate for an invention issued by the National Intellectual Property Administration. The patent is named "Hybrid Tumor Cell Line 1C2B8-2 and its Application for Secreted Antibodies", with patent number ZL 2021 11082848.X. The patentee is Through Life Diagnostics and Through Life, it is an invention patent, with application date of September 15, 2021, and a validity period of 20 years, with certificate number 8587286.